SPY424.42-0.85 -0.20%
DIA343.14-1.17 -0.34%
IXIC14,092.26-81.89 -0.58%

BRIEF-Myovant Sciences Announces Q4 Revenue Of $24.6 Mln

05/11/2021 08:34
BRIEF-Myovant Sciences Announces Q4 Revenue Of $24.6 Mln

- Myovant Sciences Ltd MYOV.N:

  • MYOVANT SCIENCES ANNOUNCES CORPORATE UPDATES AND FINANCIAL RESULTS FOR FOURTH FISCAL QUARTER AND FISCAL YEAR ENDED MARCH 31, 2021

  • Q4 REVENUE $24.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $24.6 MILLION

  • REMAIN ON TRACK TO SUBMIT U.S. REGULATORY FILING FOR ENDOMETRIOSIS IN Q2 OF CALENDAR YEAR 2021

  • QTRLY LOSS PER SHARE $0.89

  • Q4 EARNINGS PER SHARE VIEW $-0.99, REVENUE VIEW $24.6 MILLION -- REFINITIV IBES DATA

Source text for Eikon: ID:nGNXWshy3

Further company coverage: MYOV.N


(([email protected];))